25 results
8-K
EX-2.1
IKNA
Ikena Oncology Inc
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any law or regulation relating to emissions
8-K
EX-1.1
IKNA
Ikena Oncology Inc
15 May 23
Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across
9:09am
any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including
S-3
EX-1.2
b5dnckkvpz4o p7o4ts
27 Apr 22
Shelf registration
5:17pm
DEF 14A
0zzvbqup3sw6zm s4d
27 Apr 22
Definitive proxy
4:32pm
10-K
z3z h3vif
17 Mar 22
Annual report
6:31am
10-Q
qs25ni23t19bxs4rar
13 May 21
Quarterly report
4:15pm
424B4
he7iwv6 vxiekc24
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
jkhyvxhzl3z 2g
22 Mar 21
IPO registration (amended)
8:51am
S-1/A
EX-1.1
psq1sb8am4hg9fz
22 Mar 21
IPO registration (amended)
8:51am
S-1
zoo9 13mmkvxbv1uckw
5 Mar 21
IPO registration
2:59pm